Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time

A Vaccine Safety Datalink study

Lisa A. Jackson, Kathleen M. Neuzil, James Baggs, Robert Davis, Steve Black, Kristi M. Yamasaki, Ed Belongia, Kenneth M. Zangwill, John Mullooly, James Nordin, S. Michael Marcy, Frank DeStefano

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

OBJECTIVES. Children <9 years of age do not respond optimally to a first dose of trivalent inactivated influenza vaccine, and so 2 doses of trivalent inactivated influenza vaccine are recommended for children <9 years of age who are being vaccinated for the first time. We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations. POPULATION AND SETTING. We evaluated 125 928 children 6 months through 8 years of age who were enrolled in health maintenance organizations in the United States participating in the Vaccine Safety Datalink project and who received their first dose of trivalent inactivated influenza vaccine in the 2001-2002, 2002-2003, or 2003-2004 influenza seasons. RESULTS. Compliance with the 2 dose recommendations varied by age group and influenza season. Among children 6 to 23 months of age, the proportion of first-vaccinated children who received a second vaccination was 44% in 2001-2002, 54% in 2002-2003, and 29% in 2003-2004. Among children 2 to 8 years of age, the corresponding proportions were 15%, 24%, and 12%, respectively. In all seasons, compliance with the second vaccination was highest in children first vaccinated by mid-November. CONCLUSIONS. The majority of children who received their first dose of trivalent inactivated influenza vaccine did not complete the 2-dose series. The recently expanded recommendation for universal vaccination of children 6 to 59 months of age and their household contacts will substantially increase the number of children targeted for a first influenza vaccination. Noncompliance with the 2-dose trivalent inactivated influenza vaccine series may be associated with suboptimal protection against infection, which may impact the magnitude of the direct and indirect benefits achieved by the vaccination program.

Original languageEnglish (US)
Pages (from-to)2032-2037
Number of pages6
JournalPediatrics
Volume118
Issue number5
DOIs
StatePublished - Nov 1 2006
Externally publishedYes

Fingerprint

Inactivated Vaccines
Influenza Vaccines
Vaccines
Safety
Vaccination
Human Influenza
Health Maintenance Organizations
Cohort Studies
Retrospective Studies
Age Groups

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health

Cite this

Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time : A Vaccine Safety Datalink study. / Jackson, Lisa A.; Neuzil, Kathleen M.; Baggs, James; Davis, Robert; Black, Steve; Yamasaki, Kristi M.; Belongia, Ed; Zangwill, Kenneth M.; Mullooly, John; Nordin, James; Marcy, S. Michael; DeStefano, Frank.

In: Pediatrics, Vol. 118, No. 5, 01.11.2006, p. 2032-2037.

Research output: Contribution to journalArticle

Jackson, LA, Neuzil, KM, Baggs, J, Davis, R, Black, S, Yamasaki, KM, Belongia, E, Zangwill, KM, Mullooly, J, Nordin, J, Marcy, SM & DeStefano, F 2006, 'Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: A Vaccine Safety Datalink study', Pediatrics, vol. 118, no. 5, pp. 2032-2037. https://doi.org/10.1542/peds.2006-1422
Jackson, Lisa A. ; Neuzil, Kathleen M. ; Baggs, James ; Davis, Robert ; Black, Steve ; Yamasaki, Kristi M. ; Belongia, Ed ; Zangwill, Kenneth M. ; Mullooly, John ; Nordin, James ; Marcy, S. Michael ; DeStefano, Frank. / Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time : A Vaccine Safety Datalink study. In: Pediatrics. 2006 ; Vol. 118, No. 5. pp. 2032-2037.
@article{b08dba08b52b4741bb024fbae532ecfe,
title = "Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: A Vaccine Safety Datalink study",
abstract = "OBJECTIVES. Children <9 years of age do not respond optimally to a first dose of trivalent inactivated influenza vaccine, and so 2 doses of trivalent inactivated influenza vaccine are recommended for children <9 years of age who are being vaccinated for the first time. We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations. POPULATION AND SETTING. We evaluated 125 928 children 6 months through 8 years of age who were enrolled in health maintenance organizations in the United States participating in the Vaccine Safety Datalink project and who received their first dose of trivalent inactivated influenza vaccine in the 2001-2002, 2002-2003, or 2003-2004 influenza seasons. RESULTS. Compliance with the 2 dose recommendations varied by age group and influenza season. Among children 6 to 23 months of age, the proportion of first-vaccinated children who received a second vaccination was 44{\%} in 2001-2002, 54{\%} in 2002-2003, and 29{\%} in 2003-2004. Among children 2 to 8 years of age, the corresponding proportions were 15{\%}, 24{\%}, and 12{\%}, respectively. In all seasons, compliance with the second vaccination was highest in children first vaccinated by mid-November. CONCLUSIONS. The majority of children who received their first dose of trivalent inactivated influenza vaccine did not complete the 2-dose series. The recently expanded recommendation for universal vaccination of children 6 to 59 months of age and their household contacts will substantially increase the number of children targeted for a first influenza vaccination. Noncompliance with the 2-dose trivalent inactivated influenza vaccine series may be associated with suboptimal protection against infection, which may impact the magnitude of the direct and indirect benefits achieved by the vaccination program.",
author = "Jackson, {Lisa A.} and Neuzil, {Kathleen M.} and James Baggs and Robert Davis and Steve Black and Yamasaki, {Kristi M.} and Ed Belongia and Zangwill, {Kenneth M.} and John Mullooly and James Nordin and Marcy, {S. Michael} and Frank DeStefano",
year = "2006",
month = "11",
day = "1",
doi = "10.1542/peds.2006-1422",
language = "English (US)",
volume = "118",
pages = "2032--2037",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "5",

}

TY - JOUR

T1 - Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time

T2 - A Vaccine Safety Datalink study

AU - Jackson, Lisa A.

AU - Neuzil, Kathleen M.

AU - Baggs, James

AU - Davis, Robert

AU - Black, Steve

AU - Yamasaki, Kristi M.

AU - Belongia, Ed

AU - Zangwill, Kenneth M.

AU - Mullooly, John

AU - Nordin, James

AU - Marcy, S. Michael

AU - DeStefano, Frank

PY - 2006/11/1

Y1 - 2006/11/1

N2 - OBJECTIVES. Children <9 years of age do not respond optimally to a first dose of trivalent inactivated influenza vaccine, and so 2 doses of trivalent inactivated influenza vaccine are recommended for children <9 years of age who are being vaccinated for the first time. We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations. POPULATION AND SETTING. We evaluated 125 928 children 6 months through 8 years of age who were enrolled in health maintenance organizations in the United States participating in the Vaccine Safety Datalink project and who received their first dose of trivalent inactivated influenza vaccine in the 2001-2002, 2002-2003, or 2003-2004 influenza seasons. RESULTS. Compliance with the 2 dose recommendations varied by age group and influenza season. Among children 6 to 23 months of age, the proportion of first-vaccinated children who received a second vaccination was 44% in 2001-2002, 54% in 2002-2003, and 29% in 2003-2004. Among children 2 to 8 years of age, the corresponding proportions were 15%, 24%, and 12%, respectively. In all seasons, compliance with the second vaccination was highest in children first vaccinated by mid-November. CONCLUSIONS. The majority of children who received their first dose of trivalent inactivated influenza vaccine did not complete the 2-dose series. The recently expanded recommendation for universal vaccination of children 6 to 59 months of age and their household contacts will substantially increase the number of children targeted for a first influenza vaccination. Noncompliance with the 2-dose trivalent inactivated influenza vaccine series may be associated with suboptimal protection against infection, which may impact the magnitude of the direct and indirect benefits achieved by the vaccination program.

AB - OBJECTIVES. Children <9 years of age do not respond optimally to a first dose of trivalent inactivated influenza vaccine, and so 2 doses of trivalent inactivated influenza vaccine are recommended for children <9 years of age who are being vaccinated for the first time. We conducted a population-based retrospective cohort study to evaluate compliance with the 2-dose trivalent inactivated influenza vaccine recommendations. POPULATION AND SETTING. We evaluated 125 928 children 6 months through 8 years of age who were enrolled in health maintenance organizations in the United States participating in the Vaccine Safety Datalink project and who received their first dose of trivalent inactivated influenza vaccine in the 2001-2002, 2002-2003, or 2003-2004 influenza seasons. RESULTS. Compliance with the 2 dose recommendations varied by age group and influenza season. Among children 6 to 23 months of age, the proportion of first-vaccinated children who received a second vaccination was 44% in 2001-2002, 54% in 2002-2003, and 29% in 2003-2004. Among children 2 to 8 years of age, the corresponding proportions were 15%, 24%, and 12%, respectively. In all seasons, compliance with the second vaccination was highest in children first vaccinated by mid-November. CONCLUSIONS. The majority of children who received their first dose of trivalent inactivated influenza vaccine did not complete the 2-dose series. The recently expanded recommendation for universal vaccination of children 6 to 59 months of age and their household contacts will substantially increase the number of children targeted for a first influenza vaccination. Noncompliance with the 2-dose trivalent inactivated influenza vaccine series may be associated with suboptimal protection against infection, which may impact the magnitude of the direct and indirect benefits achieved by the vaccination program.

UR - http://www.scopus.com/inward/record.url?scp=33750965085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750965085&partnerID=8YFLogxK

U2 - 10.1542/peds.2006-1422

DO - 10.1542/peds.2006-1422

M3 - Article

VL - 118

SP - 2032

EP - 2037

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 5

ER -